Epidemiology of HIV/AIDS - United States, 1981-2005

Morbidity and Mortality Weekly Report

Volumn 55, Issue 21, 2006, Pages 589-592

  Schneider, E ^a   Glynn, M K ^a   Kajese, T ^a   McKenna, M T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; UNITED STATES;

EID: 33744457664     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (15)

1. CDC. Pneumocystis pneumonia - Los Angeles. MMWR 1981;30:250-2.
2. Glynn MK, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003 [Abstract T1-B1101]. Presented at the 2005 National HIV Prevention Conference, Atlanta, Georgia; June 14, 2005.
3. CDC. HIV/AIDS surveillance report 2004. Vol. 16. Atlanta, Georgia: US Department of Health and Human Services, CDC; 2005. Available at http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2004report/default. htm.
4. Nakashima AK, Fleming PL. HIV/AIDS surveillance in the United States, 1981-2001. AIDS 2003;32:68-85.
5. CDC. Trends in HIV/AIDS diagnoses - 33 states, 2001-2004. MMWR 2005;54:1149-53.
6. CDC. Racial/ethnic disparities in diagnoses of HIV/AIDS - 33 states, 2001-2004. MMWR 2006;55:121-5.
7. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr 2005;38:96-103.
8. CDC. Evolution of HIV/AIDS prevention programs - United States, 1981-2006. MMWR 2006;55:597-603.
9. CDC. HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men - five US cities, June 2004-April 2005. MMWR 2005;54:597-601.
10. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
11. CDC. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 1999;48(No. RR-13).
12. US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Rockville, MD: US Department of Health and Human Services; May 4, 2006. Available at http://AIDSinfo.nih.gov.
13. Bennett D. HIV-1 genetic diversity surveillance in the United States. J Infect Dis 2005;192:4-9.
14. Longini IM, Clark WS, Byers RH, et al. Statistical analysis of the stages of HIV infection using a Markov model. Statist Med 1989;8:831-43.
15. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42-8.